Abbreviated New Drug Application

An Abbreviated New Drug Application (ANDA) is an application for a U.S. generic drug approval for an existing licensed medication or approved drug. A generic drug product is one that is comparable to a patented drug product in dosage form, strength, route of administration, quality, performance characteristics, and intended use.

This neuron ends here.